Advisory Research’s Pontem Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 PNTM.WS Stock Holding History

Advisory Research’s Portfolio PNTM.WS Stock Details PNTM.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-72,105	Closed	-$10K	–	423
2022 Q2	$10K	Hold	72,105	–	–	﹤0.01%	349
2022 Q1	$23K	Hold	72,105	–	–	﹤0.01%	382
2021 Q4	$64K	Sell	72,105 -862	-1%	-$693	0.01%	325
2021 Q3	$52K	Hold	72,967	–	–	﹤0.01%	334
2021 Q2	$72K	Sell	72,967 -14,791	-17%	-$12.2K	﹤0.01%	335
2021 Q1	$66K	Buy	+87,758	New	+$88K	﹤0.01%	333

Other funds holding PNTM.WS

RCM

Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return

SCM

Segantii Capital Management Hong Kong $1.54B AUM 16.73% 1-Year Est. Return

LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

AFM

Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return

Advisory Research's PNTM.WS Position: Q3 2022 in Review

Advisory Research sold out of Pontem Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 (PNTM.WS) in Q3 2022, closing a stake of 72,105 shares — an estimated $10K sold.

Advisory Research first reported a position in PNTM.WS in Q1 2021 and held it in 6 quarters. The position peaked at $72K in Q2 2021. 66 funds tracked by Wall St. Rank hold PNTM.WS as of Q3 2022.

Advisory Research reported no remaining Pontem Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position as of Q3 2022 after selling out during the quarter.
Advisory Research sold 72,105 Pontem Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 shares in Q3 2022, an estimated $10K.
Advisory Research first reported a position in Pontem Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 in Q1 2021 and held it in 6 quarters.
Advisory Research's Pontem Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position peaked at $72K in Q2 2021.
66 funds tracked by Wall St. Rank held Pontem Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 as of Q3 2022.

Based on Advisory Research's 13F filing for Q3 2022, filed 15 Nov 2022.